Antipsychotics II

Atypical antipsychotics are medications used to treat mental health disorders such as schizophrenia and bipolar disorder. They have unique characteristics that differentiate them from typical antipsychotics, which were the original class of antipsychotic medications. Here’s a more detailed breakdown of their properties and some specific examples of atypical antipsychotics:

  • Definition and Characteristics Atypical antipsychotics are generally defined by:

    • They have a lower tendency to cause extrapyramidal symptoms (EPS), which are drug-induced movement disorders. EPS can include tremors, rigidity, and other involuntary muscle movements. This means that patients taking atypical antipsychotics often experience fewer movement-related side effects compared to those on typical antipsychotics.

    • They also have a lower tendency to cause hyperprolactinemia, which is an increase in prolactin levels that can lead to side effects like breast enlargement and lactation in both men and women. This is important because it means patients can maintain a more normal hormonal balance while on these medications.

    • Pharmacology:

      • These medications act as weaker dopamine D2 receptor antagonists, meaning they block the effects of dopamine, a neurotransmitter, but not as strongly as typical antipsychotics.

      • They are stronger serotonin 5-HT2A receptor antagonists than typical antipsychotics. This means they block serotonin receptors more effectively, which may help improve mood and reduce psychotic symptoms.

Major Atypical Antipsychotics

  • Clozapine

    • Brand Name: Clozaril

    • Characteristics:

    • Clozapine was the first atypical antipsychotic available, significantly changing the treatment landscape.

    • It has lower side effects related to EPS, which helps improve patients' willingness to stay on medication and maintain treatment adherence.

    • Efficacy:

    • Clozapine has the highest efficacy among atypical antipsychotics. This means it is very effective in treating symptoms of schizophrenia, especially in patients who have not responded to other treatments (known as treatment-resistant schizophrenia). Some patients previously resistant to typical antipsychotics show a 50% response rate when switching to clozapine.

    • It may also help improve negative symptoms of schizophrenia, which can include a lack of motivation or withdrawal from social activities.

    • Risks:

    • Agranulocytosis is a serious side effect involving a significant drop in white blood cell count, leading to a higher risk of infections. This occurs in about 1-2% of patients.

    • Because of this risk, blood monitoring is mandatory for the first six months of treatment, which checks the patient's white blood cell count to ensure safety. Monitoring requirements may reduce later to every other week and then monthly after the first six months.

    • Side Effects:

    • Patients taking clozapine often experience high sedation and significant weight gain.

    • There can also be long-term risks such as obesity, diabetes, and hyperlipidemia (high levels of fats in the blood).

    • Additionally, clozapine can lower the seizure threshold, increasing the risk of seizures for some individuals.

  • Olanzapine

    • Brand Name: Zyprexa

    • Characteristics:

    • Olanzapine is recognized as the second most effective atypical antipsychotic and is widely used in the United States due to its effectiveness.

    • Efficacy:

    • It has similar efficacy to typical antipsychotics. This means it works effectively in treating the symptoms of psychosis, and it can also be used during acute (sudden and severe) psychotic episodes.

    • Risks:

    • Patients may face a high propensity for sedation as a side effect, meaning they might feel excessively sleepy or drowsy.

    • Olanzapine is known to potentially cause metabolic side effects, which can lead to metabolic syndrome, a collection of health issues that increases the risk of heart disease.

    • It’s not uncommon for patients to gain over 10 pounds in the first few weeks of starting treatment, with a 7% increase in baseline weight being possible.

  • Risperidone

    • Brand Name: Risperdal

    • Characteristics:

    • Risperidone is the most potent D2 receptor blocker among atypical antipsychotics, meaning it effectively blocks dopamine at the receptor sites.

    • It has less blockade of other receptors compared to other atypical antipsychotics, which may lead to fewer side effects related to other neurotransmitter systems.

    • Efficacy:

    • While effective, risperidone can be associated with a greater risk of EPS and hyperprolactinemia, especially when taken at higher doses. This means that as the dose increases, the likelihood of experiencing these side effects also increases.

    • Some sedative effects, similar to those seen in olanzapine, have also been noted.

  • Criterapine

    • Brand Name: CereQ

    • Characteristics:

    • The structure of criterapine is similar to clozapine, which gives it certain similar properties.

    • It’s particularly noted for being highly sedative due to its action as an H1 receptor antagonist.

    • Efficacy:

    • Criterapine may benefit Parkinson's disease patients who experience psychosis as part of their condition.

    • It is particularly weak as a D2 blocker, which means it mainly impacts dopamine pathways overly involved in psychosis rather than those that control movement.

  • Zeprazodone

    • Brand Name: Geodone

    • Characteristics:

    • Zeprazodone has a modest affinity for various non-dopamine receptor subtypes, making it less typical as a treatment option.

    • It offers milder side effects compared to other antipsychotics, like less sedation and a lower risk of postural hypotension (a drop in blood pressure when standing).

    • It’s often considered weight-neutral, meaning it is less likely to cause weight gain compared to other medications.

    • Risks:

    • Zeprazodone is associated with a prolonged QTc interval, which can affect heart rhythm. Because of this, it is contraindicated for patients with a history of heart issues, meaning it should not be used in those patients.

  • Aripiprazole

    • Brand Name: Abilify

    • Characteristics:

    • Aripiprazole is unique as it is a partial D2 agonist, meaning it activates dopamine receptors but only to a limited extent (about 30%).

    • Efficacy:

    • This medication helps to mitigate excessive dopamine effects, which can be beneficial in treating psychosis, while still providing some activation at the receptor for mood regulation.

    • Aripiprazole is also used for treating depression in some cases.

    • It is often contraindicated in elderly patients with dementia due to risks of cognitive decline.

    • Sedation:

    • It is noted to be minimally sedative, making it a good option for patients who need to maintain their focus during the day, like busy office workers or truck drivers.

Comparative Analyses

  • Pharmacological Features of Atypical vs. Typical Antipsychotics

    • Atypicals are considered less potent D2 antagonists and stronger serotonin blockers compared to typical antipsychotics, which have higher potency in blocking dopamine. This discrepancy can lead to varying side effects and levels of effectiveness depending on the patient's condition.

  • Selection of Antipsychotics

    • The choice of antipsychotic medications often depends on the expected side effects rather than solely on their effectiveness.

    • Factors to consider include:

    • The patient's history of drug response, which includes how they have responded to medications in the past.

    • Medication compliance, or how well a patient can consistently take their medications as prescribed.

    • The severity and type of symptoms the patient experiences, whether they are positive symptoms (like hallucinations or delusions) or negative symptoms (like emotionless behavior).

    • Individual variability in drug effectiveness is also key, as different patients may respond differently to the same medication.

Summary of Drugs Discussed

  • Chlopromazine: The first antipsychotic discovered, notable for its low potency, high sedation effects, and significant risk of EPS side effects.

  • Haloperidol: Known as the second typical antipsychotic, it has high potency but is also associated with strong EPS concerns.

  • Clozapine: This atypical antipsychotic is effective for refractory schizophrenia but has a serious risk of agranulocytosis.

  • Olanzapine: A commonly used atypical that treats acute psychosis but has risk factors related to metabolic syndrome.

  • Risperidone: A strong D2 blocker with noted sedation and EPS concerns.

  • Criterapine: Suitable for those with Parkinson's-related psychosis and known for its high sedation effects.

  • Zeprazodone: A milder atypical, weight-neutral but contraindicated in patients with heart problems.

  • Aripiprazole: A unique partial agonist that is minimally sedative and used for patients who need to maintain focus, particularly in elderly patients when managing dementia care.

Conclusion

Discussions within the field of psychiatry and treatment of schizophrenia highlight the complexities involved in employing antipsychotic medications. It emphasizes the importance of individualized approaches that consider patient-specific factors and the potential side effects of various medications in order to optimize treatment outcomes.